AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02164565 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: control grup: without Tranexamic Acid (TXA) treatment.
Description: control grup: without Tranexamic Acid (TXA) treatment.
Study NCT02201823 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABTL0812
Description: ABTL0812. Five cohorts and one extension phase.
Study NCT03094247 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin
Description: All patients with severe acute malnutrition will receive a course of amoxicillin.
Study NCT03094247 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Description: All patients with severe acute malnutrition will receive a course of amoxicillin.
Study NCT02767791 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: Acupuncture
Study NCT03094247 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: HO-RUTF
Description: HO-RUTF: Milk, perilla oil, palm oil, white sugar, high oleic peanuts
Study NCT03094247 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: D-HO-RUTF
Description: D-HO-RUTF: DHA, milk, perilla oil, palm oil, white sugar, high oleic peanuts
Study NCT03094247 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: S-RUTF
Description: S-RUTF: Milk, canola oil, palm oil, white sugar, standard peanuts
Study NCT02767791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Acupuncture
Study NCT02767791 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Auriculotherapy
Description: Auriculotherapy
Study NCT02767791 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auriculotherapy
Description: Auriculotherapy
Study NCT01020474 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: matching placebo capsules twice daily.
Study NCT01020474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pregabalin (Lyrica)
Description: 75-450mg/day pregabalin dose optimised at start of study
Study NCT03058003 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Posturography Evaluation
Description: Posturography testing using the extended modified Clinical Testing of Sensory Integration in Balance (ext_mCTSIB) protocol: the subjects will be required to stand on a hard or compliant surface in a comfortable posture, feet shoulder width, with eyes open or closed, arms to the side and free to move, gazing forward, and breathing normally, with head straight, turned right or left, flexed or extended
Study NCT03058003 — intervention group
Intervention type: OTHER
Intervention: Central Sensitization Inventory
Description: Standard chronic pain questionnaire: the subjects will be required to score each of the 25 items on a scale from 0 (never) to 4 (always)
Study NCT03872128 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregnenolone300
Description: 300mg
Study NCT03872128 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pregnenolone500
Description: 500mg
Study NCT03872128 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo
Study NCT03998150 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Holmium laser enucleation of the prostate
Description: cystoscopic transurethral enucleation of the prostate using Holmium laser (Asclepion MultiPulse HoPlus 110W and Lumenis pulse 100W and 120W)
Study NCT03998150 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bipolar plasma kinetic enucleation of the prostate
Description: cystoscopic transurethral enucleation of the prostate using bipolar plasma kinetic energy (KLS Martin Maxium or Covidien Force Triad)
Study NCT03296722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Transtheoretical Model
Description: Intervention with the Transtheoretical Model, through group and individual sessions with topics of healthy eating habits taught by a dietician, physical activity and exercise manual taught by a physical therapist, preparation of healthy food with menu taught by graduates in gastronomy, confrontation of barriers given by a psychologist. This group had a monthly monitoring during 3 months. The food plan that was prescribed to the intervention group was with the characteristics of the DASH diet, according to the most recent international guides of the ACC and AHA, for the reduction of cardiovascular risk.
Study NCT00856167 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TCM
Description: whole system Traditional Chinese Medicine, including acupuncture, herbs, tuina, lifestyle counseling
Study NCT00856167 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-care for TMD
Description: a 5-session 8 hour intervention targeting TMD knowledge, stretching and exercises, stress reduction, lifestyle modification
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Description: Pharmaceutical form: Tablet~Route of administration: Oral
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Insulin glargine (HOE901)
Description: Pharmaceutical form: Solution~Route of administration: Subcutaneous
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine (HOE901)
Description: Pharmaceutical form: Solution~Route of administration: Subcutaneous
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: Tablet~Route of administration: Oral
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Pharmaceutical form: Tablet~Route of administration: Oral
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Oral Antidiabetes Drugs (OADs)
Description: OADs (including metformin) as prescribed by the investigator as per local labeling.
Study NCT03285594 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Antidiabetes Drugs (OADs)
Description: OADs (including metformin) as prescribed by the investigator as per local labeling.
Study NCT02213263 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PF-05280586
Description: PF-05280586 (rituximab-Pfizer) concentrate for solution for infusion 375mg/m2 administered via IV infusion on Days 1, 8, 15, and 22
Study NCT02213263 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: MabThera®
Description: MabThera® (rituximab-EU) concentrate for solution for infusion 375mg/m2 administered via IV infusion on Days 1, 8, 15, and 22
Study NCT01673672 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CYT003
Description: 7 subcutaneous injections, weekly/biweekly within 10 weeks
Study NCT01673672 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 7 subcutaneous injections, weekly/biweekly within 10 weeks
Study NCT00688779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD8848
Description: Concentrate for nasal spray,solution 60 mg/g
Study NCT00688779 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT01105130 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Given orally
Study NCT01105130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Given orally
Study NCT01105130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral L-Arginine
Description: Given orally 3 capsules ArginMax and 3 Placebo capsules
Study NCT01105130 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral L-Arginine
Description: Patients will take 6 capsules of ArginMax twice daily
Study NCT05016336 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Social interaction combined with cognitive training based on mnemonic strategies.
Description: In the first six sessions, participants in the experimental group learned and practiced six different mnemonic strategies: Story-Formation strategy, Face-Name strategy, Peg-Word strategy, Chunking strategy, Key-Word strategy and the Method of Loci. In the following six sessions, in order to assimilate the strategies they learned, participants practiced the same tasks.
Study NCT05016336 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Social interaction group
Description: In the control group, each session also began with a conversation between the participants. The sessions then dealt with the content of interpersonal communication and the acquisition of tools for creating interpersonal relationships. Participants were asked to share the way they used the tools they acquired between sessions and received feedback from the other participants
Study NCT02274428 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: pneumostem
Description: human umbilical cord blood derived mesenchymal stem cells
Study NCT00856102 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Home-base walking program
Study NCT00856102 — intervention group
Intervention type: BEHAVIORAL
Group type: NO_INTERVENTION
Intervention: Control
Description: Usual care
Study NCT02463877 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally-Invasive Procedure
Description: Laparoscopy
Study NCT00739570 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AAI signature IV AMCT
Description: Chiropractic adjustments of the lumbar spine following the activator basic scan protocol
Study NCT04137887 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Quadrivalent Influenza Vaccine (split virion, inactivated) High-Dose (QIV-HD)
Description: Pharmaceutical form: Suspension for injection in pre-filled syringe Route of administration: Intramuscular
Study NCT04137887 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard-Dose Inactivated Influenza Vaccine Quadrivalent, Northern Hemisphere strains (QIV-SD)
Description: Pharmaceutical form: Suspension for injection in pre-filled syringe Route of administration: Intramuscular
Study NCT00552903 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health coaching
Description: Personal health coach providing advice and counselling by telephone, weekly contacts
Study NCT01371760 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Venous PTA
Description: PTA of the internal jugular and/or azygous vein
Study NCT01371760 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Catheter Venography
Description: The patients will undergo catheter venography but not PTA
Study NCT04764539 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Video Assisted Speech Therapy (VAST)
Description: Six children with ASD, between the ages of 4 and 8, participated in a 14-sessions-long study that utilized the VR-integrated and the tablet-based VAST application. Three subjects received a 3D VR-integrated, bone conduction VAST prototype, while the remaining group of three received a tablet with a 2D version of the software. Sessions were held twice a week with each lasting approximately 15 minutes (i.e. +/- 5 minutes).
Study NCT00218894 — intervention group
Intervention type: PROCEDURE
Intervention: Cataract surgery
Description: surgery one one or two eyes by use of two different types of lenses and correcting for refraction
Study NCT00368849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: atomoxetine
Description: This study utilizes a crossover design. Accordingly, half of the participants receive 40 milligram twice a day atomoxetine at arm one while the remaining half receive this intervention at arm two.
Study NCT00368849 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching Placebo
Description: This study utilizes a crossover design. Accordingly, half of the participants receive twice a day matching placebo at arm one while the remaining half receive this intervention at arm two.
Study NCT00224718 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endovascular repair (with endograft)
Description: An endovascular stent graft is a tube composed of fabric supported by a metal mesh called a stent. It can be used for a variety of conditions involving the blood vessels, but most commonly to reinforce a weak spot in an artery called an aneurysm. Over time, blood pressure and other factors can cause this weak area to bulge like a balloon and eventually enlarge and rupture. The stent graft seals tightly with your artery above and below the aneurysm. The graft is stronger than the weakened artery and allows blood to pass through it without pushing on the bulge. Physicians typically use endovascular stent grafting to treat abdominal aortic aneurysms (AAAs).
Study NCT00224718 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Open repair
Description: Conventional repair consist in open repair. Different types of surgery can be done : minimal incision aortic surgery (MIAS), transperitoneal approach (TPA), retroperitoneal repair, or conventional median laparotomy.
Study NCT01344863 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: trastuzumab [Herceptin]
Description: 600 mg subcutaneously using a single-use injection device on Day 1
Study NCT01344863 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: trastuzumab [Herceptin]
Description: 600 mg subcutaneously using a handheld syringe on Day 1
Study NCT01910753 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: APA
Description: A 3-month program for physical activity and diet education will be followed. An exercise specialist will supervise patients twice per week, during the first six weeks. They will also follow nutrition counselling and therapeutic education by a dietician once per week. During the last six weeks, they will just follow a guide for safe and appropriate exercise regimen. The dietician will call patient weekly during this final period.
Study NCT02102815 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 0.15mg/kg mixed with NSS up to 50 mL IV slowly push over 5 minutes
Study NCT02102815 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: NSS 50 mL IV slowly push over 5 minutes
Study NCT02412553 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Specific carbohydrate diet
Study NCT02412553 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Elemental diet
Study NCT03890237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Her Spaces
Description: Her Spaces will comprise a set of activities leveraging the Her Spaces curriculum and program model which includes curriculum-based sessions for 11-13 year old girls, with 40 sessions delivered weekly over the course of 10 months
Study NCT03890237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Act With Her
Description: Act With Her was designed to facilitate adolescent transitions to adulthood via improvements across the six GAGE domains (education, bodily integrity, health, psychosocial well-being, voice and agency, and economic empowerment). Project activities fall into three main categories: curriculum-based programming with adolescent girls and boys, community transformation, and systems strengthening. Act With Her will work with 10-13 year old girls and boys for 10 months and implement community-level and high-level system strengthening work up to 24 months (in rural and pastoralist areas).
Study NCT03890237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Act With Her + Asset Transfer
Description: This arm will implement the Act With Her program described above, using program curricula with 10-13-year-old girls and boys over 10 months and conducting community-level systems strengthening up to 24 months. Additionally, the girls participating in this arm will receive one of three asset transfer options. The packages will be of equal value (115 USD) - one will include school supplies, one will include hygiene supplies, and will be a combination of both. Each adolescent girl will choose which package she would like to receive and will receive components of the package at 3 timepoints over the course of the first 10 months of the project.
Study NCT03890237 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Act With Her (simple)
Description: This arm will implement the Act With Her curricula described above with 10-13 year old girls and boys over 10 months. The adolescent groups will follow the same model (near-peer, same-sex mentors, 40 weekly meetings for girls, 18 meetings for boys, 4 of which are joint sessions for boys and girls, 6 sessions for parents), but will not include community-level systems strengthening activities
Study NCT01440803 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Teriparatide
Description: Daily injection of 20 mcg teriparatide for the treatment of idiopathic osteoporosis for 24 months.
Study NCT01440803 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline Placebo
Description: Daily injection of saline placebo for 6 months, followed by teriparatide treatment for 24 months.
Study NCT02507128 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: liraglutide
Description: Liraglutide were taken 30 min before PCI.
Study NCT02507128 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo were taken 30 min before PCI.
Study NCT04073576 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AHCL
Description: Closed loop algorithm contained in the MiniMed™ 670G 4.0 pump to be used in the study; includes a modified proportional integrative derivative (PID) model, with insulin feedback, an auto correction bolus feature and additional safety features.
Study NCT04073576 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SAP+PLGM
Description: Sensor Augmented Pump (SAP) Therapy Mode with Predictive Low Glucose Management (PLGM), contained in the the MiniMed™ 670G 4.0 pump to be used in the study.
Study NCT00926120 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mogroside sweetener (PureLo)
Description: Mogroside sweetener administered at a dosage level of 5g every 6 hours for 14 days
Study NCT01926639 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Radiotherapy, rituximab and DC
Description: Lymphoma lymph nodes are irradiated with 8 Gy single treatment and injected with rituximab (5 mg) and autologous DC intratumorally. The treatment is performed 3 times targeting different lymph nodes
Study NCT01155323 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: etafilcon A
Description: 1-day soft contact lens
Study NCT01155323 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: omafilcon A
Description: 1-day soft contact lens
Study NCT05018559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BuG lesson
Description: Participants of the intervention group in nursing care received a co-created setting-specific intervention to promote physical activity called BuG lesson. The BuG lesson comprises a weekly 90-minute lesson for apprentices of nursing care during regular school hours, covering physical activity and health in theory and practice. Previously, the nursing teachers voluntarily underwent a qualification process as physical activity instructors, enabling them to conduct the BuG lessons independently.
Study NCT05018559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tutoring system
Description: Participants of the intervention group in automotive mechatronics received a co-created setting-specific intervention to promote physical activity called tutoring system. In the tutoring system, automotive mechatronics apprentices act as physical activity promotors for their fellow apprentices. In the sense of a peer-to-peer approach, apprentices voluntarily participate in a workshop to be qualified as tutors. Subsequently, the tutoring system takes place every two weeks for about ten to fifteen minutes during regular working hours, allowing the tutors to discuss the issues of physical activity and health among their peers.
Study NCT00356590 — intervention group
Intervention type: BIOLOGICAL
Group type: OTHER
Intervention: Etanercept
Description: Etanercept (TNFR:Fc) will be administered 50 mg per week as two 25 mg subcutaneous injections at separate sites, given either on the same day or 3 or 4 days apart.
Study NCT03516500 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron Sucrose Injection
Description: The investigators inject Iron Sucrose (100 mg dissolved in 50 mL saline) into the segmental bronchus.
Study NCT02714738 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound guided peripheral nerve block
Description: Ultrasound guided peripheral nerve block
Study NCT05015179 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mixed reality technology in laparoscopic partial nephrectomy
Description: All patients undergo contrast-enhanced computed tomography before surgery. DICOM files are converted to a 3D model. This model is then sent to HoloLens 2 smart glasses using HLOIA software
Study NCT03759522 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DPA-714 PET/MRI
Description: DPA-714 PET/MRI
Study NCT02710058 — intervention group
Intervention type: BEHAVIORAL
Intervention: one-time qualitative assessment
Description: The study involves a one-time qualitative assessment to explore key cultural influences on AMBER breast cancer survivors' health behavior. We will focus on self-efficacy in healthcare, coping with breast cancer, social networks of support, and culturally-sensitive support groups. The study investigator will administer questions from the structured interview guide, estimated to take 90 minutes.
Study NCT00871793 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Occupational therapy
Description: Participants in this arm will receive six sessions of occupational therapy in a 5 week period.